NMD4C and MDC Announce Plans for Neuromuscular Community of Practice
Together with Muscular Dystrophy Canada we are thrilled to announce a new community of practice (COP) initiative for healthcare professionals (HCP) who care for patients with neuromuscular disease.
In response to the dynamic and rapidly advancing landscape of therapies for neuromuscular disorders (NMDs), this CoP will address the need for a centralized hub for neuromuscular HCPs, fostering collaboration, knowledge exchange, and skill enhancement to elevate NMD research and care across Canada.
Providing Support Where It’s Needed
The CoP will offer opportunities for knowledge exchange and joint upskilling for neuromuscular HCPs nationwide. Many Canadian HCPs encounter limitations in exchanging ideas and accessing tailored neuromuscular training from outside of their individual healthcare centers. The CoP will bridge these gaps to provide specific training opportunities to collectively strengthen and unite neuromuscular HCPs across Canada.
Focused Areas of Impact
We will focus initially on key areas where specific training and collaboration will provide the most benefit, including training for conducting clinical trials in Canada, advancing physical medicine and rehabilitation, and conducting outcome measures for NMD therapies, which are crucial for supporting therapy reimbursement in Canada.
Who Is This CoP For?
The CoP will facilitate connections primarily among rehabilitation specialists, physiatrists, and clinical trial coordinators. We aim to create an inclusive environment where expertise from a variety of roles is welcomed, and we invite neuromuscular stakeholders from beyond these roles to join us.
How to Get Involved
Individuals who are interested in participating in the CoP can express their interest by joining the NMD4C. If you are already a member of the network, we will provide updates soon on how you can participate in the CoP! Join the NMD4C to be contacted about the CoP!
For more information, please visit the CoP web page or contact the Community of Practice Manager Dr. Maria Masnata.
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.